setoperone has been researched along with pirenzepine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DaSilva, J; Houle, S; Jones, C; Kapur, S; Remington, G; Wilson, AA; Zipursky, RB | 1 |
| Kapur, S; Remington, G; Zipursky, RB | 1 |
1 trial(s) available for setoperone and pirenzepine
| Article | Year |
|---|---|
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Olanzapine; Pirenzepine; Prolactin; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Salicylamides; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome | 1998 |
1 other study(ies) available for setoperone and pirenzepine
| Article | Year |
|---|---|
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Clozapine; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1999 |